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A Novel Approach to Manipulate Cavity Size in Resorcinarene 
  
Sumedh Parulekar 
  
ABSTRACT 
 
 
  
Intramolecular ring closing metathesis in the presence of Grubbs’ catalyst has been used 
as an efficient approach to synthesize bridged resorcinarenes. Octaallyl cavitands may 
undergo conformational changes; however bridge formation by RCM of the allyl groups 
gives a rigid, enforced, concave cavity capable of holding neutral molecules. This is the 
first report describing tandem formation of the four bridges on the upper rim of 
resorcinarenes. Structures of bridged resorcinarenes are confirmed by spectral analysis 
data.  
This report also describes the synthesis of polyhydroxy resorcinarenes, which have been 
used as metal complexing agents, sensors, receptors, molecular reaction vessels and 
catalytic chambers. They are able to encapsulate small neutral molecules, drug molecules 
inside the cavity. Such cavitands offer unique molecular platforms for host–guest 
chemistries, as well as new polymers and self-assembled systems. 
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 CHAPTER 1. INTRODUCTION 
 
 
 
1.1. Introduction to Resorcinarene 
 
 
 
 Resorcinarenes are compounds made by condensation of resorcinol and aldehydes 
in the presence of acids. Resorcinarenes in a locked conformation result in cavitands, 
which are defined as compounds that contain an enforced cavity large enough to 
accommodate simple organic compounds or ions.1 Resorcinarene cavitands have been 
used for variety of purposes because of their rigidity, enforced cavities and synthetic 
viability.2 Resorcinarenes have been used as metal complexing agents, sensors, receptors, 
molecular reaction vessels and catalytic chambers.3 They are also able to encapsulate 
small neutral molecules such as CH2Cl2, CHCl3 and CS2 as well as drug molecules, 
photoactive components.4 Resorcinarenes also act as precursors to carceplexes, 
carcerands, hermicarcerands, as binders of neutral guest molecules and as agents to form 
monolayers.5 They can provide novel and efficient receptors with potential complexation 
towards complicated guests.6 Resorcinarene cavitands have found applications in nuclear 
waste treatment because of their ability to bind to strontium, cesium and actinides with 
high efficiency and selectivity.   
 In 1870, Adolf Von Baeyer observed a red-colored solution upon addition of 
concentrated sulfuric acid to an ethanolic solution of benzaldehyde and resorcinol.7 The 
red-colored solution yielded, in several days, a crystalline compound. In 1883, Michael 
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determined that the crystalline compound formed from an equal number of benzaldehyde 
and resorcinol molecules with loss of water molecules.8 In 1940, Vogel and Niederl9 
prepared the crystalline compound described by Baeyer and its peracetate derivative. 
Molecular weight determinations of the crystalline compound and the peracetate 
derivative led them to establish the ratio of the resorcinol and the aldehyde to be 4:4, i.e., 
each molecule of the resorcinarene contained four molecules of the resorcinol with four 
molecules of the aldehyde, of course with loss of 4 molecules of water.9 The crystal 
structure of the resorcinarene was first solved by Erdtman and coworkers in 1968, thus 
proving its structure as in figure 1. D. J. Cram synthesized the first cavitand in 1982 with 
alkylene bridge on upper rim of resorcinarene. 10  
 
HOHO OH
HO OH HO OHOH
R' R' R' R'
R RRR  
Figure 1. Structure of Resorcinarene, 
R' = H, CH3, Br, OH, etc. 
R = Aliphatic or Aromatic substituents. 
 
 In resorcinarenes the macrocyclic ring can adopt five symmetrical arrangements, 
namely, crown, chair, boat, diamond and saddle.1a,4a However, the two major preferred 
conformations are Crown (C4v) and Chair (C2v) (Figure 2), depending on reaction 
conditions, time duration and different R and R’ substituents on the cavitands.11  
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Figure 2. Conformations in Resorcinarene (Top view.) 
 
1.2. Introduction to Bridged Resorcinarenes 
  
 Intramolecular cyclization leading to conformationally locked resorcinarenes, i.e., 
cavitands, has been a key feature of synthetic procedure leading up to many of these 
encapsulating platforms. The covalent linkage of the neighboring phenolic groups on the 
adjacent phenyl rings is generally exploited for synthesis of the rigid 'bowl' shaped 
cavity. The treatment of the octahydroxy resorcinarene with excess of CH2ClBr and base 
results in formation of the methylene bridged cavitand; the most common of the covalent 
linkage reported. The synthesis of ethylene and propylene bridged cavitands has also 
been reported.12 It has been observed that compared to the methylene bridge cavitands, 
the ethylene and propylene bridged cavitands are somewhat more flexible. There are also 
reports of the dialkylsilicate-,13 phosphoryl-,14 and heterophenylene-bridged cavitands15 
(Figure 3).  
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 The length and nature of the alkylene bridge has been shown to affect the cavity 
size of the cavitand. For example, while the heterophenylene bridges deepen the cavity, 
the alkyl substituents of the silicon bridge considerably narrow the cavity.16 Clearly, the 
bridging reaction can be used to manipulate the cavity size and hence can be used to alter 
the properties of the cavitand. We realize that by the application of ring closing 
metathesis reaction, very interesting resorcinarene cavitands with unusual properties can 
be prepared. 
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Figure 3. Structure of alkylene bridged resorcinarenes, dialkylsilicate bridge 
resorcinarenes, phosphoryl bridge resorcinarenes and heterophenylene bridge 
resorcinarenes, respectively. 
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  Ring-closing metathesis (RCM) has been rapidly established as an efficient 
approach to the synthesis of medium to large ring systems.  Advancement in the design of 
the catalyst leading to their remarkable functional group tolerance, operational simplicity, 
high stability and commercial availability has greatly contributed to the popularity of the 
RCM reaction. To the best of our knowledge, there are no reports of use of RCM reaction 
in resocinarenes.  However, McKervey17 and Chen18 have reported use of RCM in 
synthesis of bridged, bis-and tetracalix[4]arenes. 
 The following chapter describes our efforts towards utility of the tandem RCM 
reactions in manipulation of the resorcinarene's cavity size.   
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CHAPTER 2. SYNTHESIS OF BRIDGED RESORCINARENES 
 
 
 
2.1. Synthesis of Octahydroxy resorcinarenes 
 
 
 
  Resorcinarenes, 1-6 were used as starting material for the preparation of 
octaallyloxy resorcinarenes. They were prepared by condensation of resorcinols and 
aldehydes in the presence of hydrochloric acid and ethanol as a solvent (Scheme 1).  The 
compounds were precipitated from ice-cold water to yield brown-colored solids. The 
condensation reactions, depending on the substrates, were carried out at reaction 
temperature ranging from 45oC to 78oC. Low reaction temperature of 45oC to 50oC was 
maintained for resorcinol condensation while the reaction mixture was brought to a reflux 
(78oC) for condensation reaction of methyl resorcinol.  Resorcinarenes from methyl 
resorcinol (1-3) were isolated in 70-90 % yield whereas those of resorcinol (4-6) in 50-
80% yield. The condensation of resorcinol at the reflux temperature led to the 
decomposition of the product and reduced yield of the 4-6 was obtained. 
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HO OH HO
HO OH
HO OH HO OHOH
R' R' R' R'
R RRR
R-CHO, Ethanol, HCl
                           
                           1   R = CH(CH2CH3)2     R' = CH3    
                           2   R = C6H13                   R' = CH3            
                           3   R = C9H19                   R' = CH3
                           4   R = CH(CH2CH3)2      R' = H
                           5   R = C6H13                   R' = H
                           6   R = C9H19                   R' = H
R'
 
Scheme 1. Condensation reaction between resorcinol and aldehyde. 
  
2.2. Allylation of Octahydroxy resorcinarenes 
 
 Resorcinarenes, 1-6 were subsequently perallylated by its reaction with allyl 
bromide in presence of potassium carbonate as a base in refluxing acetone. Reaction 
conditions were modified and optimized. When DMF and potassium tert-butoxide were 
used at 60oC, especially in case of alkyl substituents, the reaction resulted in a complex 
mixture of products in low yield of the perallylated product.  Additionally, the removal of 
DMF by distillation was tedious and might have attributed to the decomposition or side 
reactions. Allylation using acetone as a solvent and potassium carbonate as a base were 
therefore investigated. While the reactions worked well in 7-9, the reaction was 
extremely slow for compounds 10-12. The allylation was therefore investigated in a 
sealed tube, which allowed higher reaction temperature to be attained (Scheme 2). 
Reactions in sealed tube conditions were performed at 120oC and led to clean products 8 
and 9, in 60-76% yield. Compound 7, could be isolated in 36% yield. Although reactions 
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were carried out at slightly lower temperature about 90oC for resorcinol-derived 
resorcinarenes, products 10-12 were isolated in 20-22% yield. 
                           
                           7   R = CH(CH2CH3)2     R' = CH3            
                           8   R = C6H13                   R' = CH3             
                           9   R = C9H19                   R' = CH3             
                         10   R = CH(CH2CH3)2      R' = H
                         11   R = C6H13                    R' = H
                         12   R = C9H19                    R' = H
Allyl bromide, K2CO3, 
Acetone
sealed tube, 90-120oC
HOHO OH
HO OH HO OHOH
R' R' R' R'
R RRR
OO OO O O OO
R' R' R' R'
RR RR
                          1   R = CH(CH2CH3)2     R' = CH3  
                          2   R = C6H13                   R' = CH3             
                          3   R = C9H19                   R' = CH3             
                          4   R = CH(CH2CH3)2      R' = H
                          5   R = C6H13                    R' = H
                          6   R = C9H19                    R' = H  
Scheme 2. Allylation reaction of octahydroxy resorcinarene 
 
 
 Compounds 7-12 were analyzed by 1H- and 13C NMR and APCI MS data. 1H 
NMR clearly showed that changes occurred between 4.0 and 6.0 ppm after perallylation 
reaction. Allylic proton (O-CH2) appeared between 4.0-4.4 ppm, the vinylic proton 
(CH=CH2) appeared between 5.0-5.4 ppm and the non-terminal vinylic proton (CH=CH2) 
appeared between 5.8-6.0 ppm (Figure 4). In the 13C NMR spectrum, the allylic carbon 
appeared between 65.0-75.0 ppm, the terminal vinylic carbon appeared between 115.0-
120.0 ppm and the non-terminal carbon peak appeared between 125.0-130.0 ppm.   
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 OO O
O O O OO
Figure 4. 1H NMR of compound 12. 
 
 Compound 7 was crystallized out from an acetone and methanol solvent (50:50) 
system.  The ORTEP plot of 7 is shown in figure 5, which shows the macrocyclic ring in 
the preferred crown conformation with the allyloxy groups on the upper rim and the 
isopentyl groups on the lower rim. 
 
Figure 5. X-ray crystal structure of compound 7 
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2.3. Ring Closing Metathesis of Allyloxy resorcinarenes: Four bridged cavitands 
  
 Intramolecular cyclization leading to a bridged structure has been a very 
important feature of the synthesis of many of these cavitands. Ring-closing metathesis 
(RCM) is becoming a preferred approach to synthesis of medium and large sized 
macrocycles.  Advancement in the design of the catalyst leading their remarkable 
functional group tolerance, operational simplicity, high stability and commercial 
availability has greatly contributed to the popularity of the RCM reaction. However, there 
have been no reports describing use of RCM reaction for manipulating the cavity size of 
the resorcinarene cavitands.  We realized that there exists an opportunity to exploit the 
RCM reaction for manipulating the cavity size of the resorcinarene cavitands by utilizing 
multiple tandem ring closings on the upper rim (Figure 6).  Resorcinarene has two well-
defined rims; a lower rim defined by alkyl or phenyl substituents from corresponding 
aldehyde and an upper rim defined by hydroxyl groups of resorcinol. In this chapter, we 
describe our results from the study of the RCM reaction on compounds 7-12. 
OO OO O O OO
R' R' R' R'
RR RR
OO OO O O OO
R' R' R' R'
R R RR  
Figure 6. Ring closing metathesis of allyloxy resorcinarenes to bridged resorcinarenes. 
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 As described in the previous section, upper rim hydroxyl groups in 1-6 were 
allylated to synthesize octaallyloxy resorcinarenes, 7-12. In this investigation, we utilized 
the Grubbs’ catalyst, which has been widely used for ring closing metathesis due to its 
remarkable functional group tolerance, operational simplicity, high stability and 
commercial availability. Interesting conformational dynamics in the octaallyloxy 
resorcinarene due to its flexibility (Figure 7) resulted in interesting observations 
summarized in the following sections. 
 
Figure 7. Grubb's generation I catalyst. 
 
 The reaction was carried out under a nitrogen atmosphere using dry 
dichloromethane as a solvent. 5-8 mol % of Grubb’s catalyst was used in the reaction. 
The reaction was continued for 4 days. Thin layer chromatography showed the 
appearance of compound with lower Rf value [Rf = 0.4, ethyl acetate and hexane (20:80) 
solvent system]. It was separated on column chromatography and analyzed by 1H- and 
13C- NMR, 2D NMRs and mass spectral data. 
 In case of compounds 7-9; all four 2-butylene bridges were formed on the upper 
rim leading to the compounds 13-15 (Scheme 3) in 35-61 % yield. 
 11
                           
           7   R = CH(CH2CH3)2        
           8  R = C6H13                           
           9  R = C9H19
Grubb's catalyst, Dry DCM
R.T., 4 days
OO OO O O OO
R R RR
                           
                                     13   R = CH(CH2CH3)2           
                                     14  R = C6H13                            
                                     15  R = C9H19
OO OO O O OO
RR RR
 
Scheme 3. Ring closing metathesis of octaallyloxy resorcinarenes 7-9. 
 
 Compound 13 was obtained in 35% yield after 96h stirring the reaction mixture at 
25oC using 5 mol % of grubb's catalyst. Reactions were repeated with higher amount of 
catalyst (8 mole %) or  an additional amount of catalyst was added after 48h, but without 
higher conversion. The compound 13 was the only compound formed and the unreacted 
substrate 7 was recovered after column chromatography to be reused in the reaction to 
increase overall yield of the cavitand 13. The structure of the cavitand 13 was established 
using 1H- and 13C- NMR spectral data. Molecular weight of the compound 13 was 
determined to be 1032 g/mol [Observed m/z =1033.7 (M+H+)] from it APCI MS 
analysis.  
 In the 1H NMR spectrum of 13, the proton peaks for the (CH=CH2) groups 
observed in the 1H NMR of 7 were replaced by the peak of single alkene protons 
(HC=CH) of the bridge. Its 13C NMR spectrum, resonances that appeared at 116.0-118.0 
ppm for terminal vinyl carbons (CH=CH2) in 7 had disappeared while a new resonances 
for the bridge (HC=CH) formed after ring-closing metathesis were at 125.0-130.0 ppm.  
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 Compound 14 was isolated in 59% yield from its precursor 8. Its 1H- NMR and 
13C- NMR and mass spectral (APCI) analysis were in accordance with the four-bridged 
structure. In the 1H-NMR spectrum the alkene protons (HC=CH) were at 5.9 ppm while 
the terminal (=CH2) allylic protons of 8 were not observed (Figure 8).  Molecular weight 
of the compound 14 was determined to be 1088 g/mol [Observed m/z =1089 (M+H+)] 
from it APCI MS analysis. 
 
 
OO OO O O OO
Figure 8. 1H NMR of compound 14. 
 
 The compound 14 was crystallized from a methanol and ethyl acetate (70:30) 
solvent system. The crystal structure shows the formation of all four bridges in the upper 
rim (Figures 9 and 10). It also confirmed the tetrameric rigid structure with crown 
conformation (C4v symmetry) in which all four methyls and four bridges remain in the 
upper rim and heptyl substituents remain in the lower rim.  
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 Figure 9. X-ray crystal structure of 14 (top view). 
 
Figure 10. X-ray crystal structure of 14 (side view). 
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 X-ray diffraction analysis of recrystallized sample of 14 established its molecular 
conformation in the solid state. 56 % reflections had I > 2σ (I) in the range 2.5o < 2σ < 
23o. Crystals came out to be monoclinic, colorless prism.  The dimension of the O4-C41-
C45-O5 bridge formed between phenyl rings C8-C13 and C15-C20 are: angles 
C12C11O4, C11O4C41, O4C41C42, C41C42C43, C11C12C14, C12C14C15 were 119o, 
116o, 112o, 132o, 120o, and 113o, respectively; bond length between C42-C43 is 1.32Ao 
and between C43-C44 is 1.5Ao. The distance between two methyl groups in phenyl rings 
on the opposite side of the cavity was 8-13Ao, while the distance between the two 
carbons in the opposite bridges was determined to be 13Ao. This cavity size of the 
cavitand is considerably larger than the bridged resorcinarenes reported in the literature 
with the cavity of 8-10Ao.5,12,13,14,15 Thus we were able to manipulate the cavity size in 
cavitands by intramolecular multiple ring closing metathesis reactions on the upper rim of 
the resorcinarenes. This is the first report describing tandem formation of the four bridges 
on the upper rim of resorcinarenes. The crystal structure of compound 14 also confirmed 
that RCM reaction involved two allyl groups on the adjacent phenyl rings rather than 
those on the same phenyl ring.  
 Compound 15 was isolated in 61% yield from its precursor 9. Its 1H- NMR and 
13C- NMR and mass spectral data (APCI) were fully consistent with the intramolecular 
four-bridged-structure. The molecular weight of compound 15 was determined to be 1256 
g/mol [Observed m/z =1257 (M+H+)] from it APCI MS analysis. Compound 15 retained 
a crown cone conformation (C4v symmetry) in which all four methyls and four bridges 
remain in the upper rim and decyl chain remains in the lower rim. 
 15
 Figure 11. 13C NMR spectra show that the resonance in octaallyloxy resorcinarene 8 
between 116-118 ppm disappears when it undergoes ring closing metathesis and the 
resonance at 122 ppm becomes very prominent in compound 14. 
 
  
2.4 Synthesis of partially bridged resorcinarenes by RCM: Two bridged 
resorcinarenes. 
 
 
 RCM reaction catalyzed by the Grubb's generation I catalyst in 11 and 12 led to 
partially bridged products 16 and 17, respectively with 32-35% yield (Scheme 4).   Even 
at higher concentration of the Grubb's catalyst (8-10 mole %), formation of only two 
bridges was observed after 4 days of reaction monitoring. Unreacted 11 and 12 were 
recovered by column chromatography and reused to increase the overall yield. The 
structures of compounds 16 and 17 were established by 13C- and DEPT NMR data.  
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Molecular weights of the compound 16 was determined to be 1088 g/mol [Observed m/z 
=1089 (M+H+)] and the compound 17 was determined to be 1256 g/mol [Observed m/z 
=1257 (M+H+)] from it APCI MS analysis.  In 1H NMR spectra (Figure 12) of 16 and 17, 
two different alkene protons originating from unreacted allyl groups (5.1-5.4 ppm for the 
=CH2; 6.1 ppm for the =CH) and the alkene bridge (5.9 ppm (HC=CH) were observed.  
The appearance of only two sets of resonances for the alkenyl protons (unreacted and in 
the bridge) suggested a two-fold symmetry in compounds 16 and 17. Similar 
observations were also made from their 13C- NMR data in which the two set of 
resonances were observed for the alkenyl carbons (115.0 ppm for the =CH2; 133.0 ppm 
for the =CH form unreacted allyl group; 127 ppm C=C in the bridge) further establishing 
a two fold symmetry in the compounds.  Thus it was concluded that two bridges formed 
opposite to each other on the same upper rim side.  
 
OO OO O O OO
RR RR
Grubb's catalyst, Dry DCM
R.T., 4 days
OO OO O O OO
RR RR
16   R = C6H13               
17   R = C9H19
11   R = C6H13                 
12   R = C9H19  
Scheme 4. Ring closing metathesis of octaallyloxy resorcinarenes 11 and 12. 
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 Figure 12. 1H NMRs of compound 16 and its precursor 11. 
 
2.5 Synthesis of single bridged compounds by RCM 
 
 In compounds 18 and 19, RCM reaction led to formation of compounds 20 and 
21, respectively (Scheme 5) in 13-16% yield. Starting material was recovered by column 
chromatography and was reused in the reaction. Molecular weights of the compounds 20 
[Observed m/z = 893 (M+H+)] and 21 [Observed m/z = 837 (M+H+)] from their APCI 
MS analysis suggested formation of a single bridge by reaction of the two allyl groups on 
the adjacent phenyl rings.  
 
 18
OO OO O O OO
R' R' R' R' Grubb's catalyst, Dry DCM
R.T., 4 days
OO OO O O OO
R' R' R' R'
20  R' = CH3             
21  R'= H
18  R' = CH3             
19  R'= H  
Scheme 5. Ring Closing Metathesis of Octaallyloxy Resorcinarene18 and 19. 
 
Table 1: - Following table gives complete idea about different resorcinarene cavitands 
we prepared in our lab with different substituents. It also shows the reactions we tried to 
get those compounds and percent yield obtained in each case. 
 
 Octahydroxy 
Compounds 
Allyloxy compounds 
With different routes of allylation 
 
RCM products  
 
 
Aldehydes HCl/ Ethanol DMF/ 
KOtBu 
Acetone/ 
K2CO3
Sealed tube 
Reaction 
Grubbs’ Cat/ 
DCM 
Ethanal    (67%) -- 18  (76%)    18  (70%) 20  (13%) 
2-Ethylbutanal 1 (80%) -- 7  (35%) 7  (40%)  13  (35%) 
Heptanal 2 (88%)  -- 8  (55%)       8 (60%) 14  (59%) 
 
2-Methyl-
1,3-
resorcinol 
Decanal 3 (85%) -- 9  (54%) 9 (55%) 15  (61%) 
Ethanal    (48%) -- -- 
 
     19(78%)  21  (16%) 
2-Ethylbutanal 4 (57%) -- -- 10 (15%) -- 
Heptanal 5 (78%) -- -- 11 (22%) 16  (32%) 
 
1,3-
Resorcinol 
Decanal 6 (62%) -- -- 12 (20%) 17  (35%) 
 
  In conclusion, allylation followed by intramolecular ring closing 
metathesis by Grubb’s catalyst gave rigid enforced cavity on novel resorcinarene 
cavitands. It is the first report that describes the synthesis of rigid concave resorcinarene 
cavitands by four tandem ring closing metathesis reaction on the upper rim.  Such 
resorcinarenes have potential applications as drug carriers, receptors and sensors for ions 
and neutral molecules. 
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CHAPTER 3. SYNTHESIS OF POLYHYDROXY RESORCINARENE 
 
 
3.1. Introduction to Polyhydroxy resorcinarenes 
 
 
  
 Resorcinarene cavitands with heptyl substituent and methylene bridge (Figure 13) 
could be used in the synthesis of bioactive compounds, drug carriers, precursors to 
formation of hemicarplexes, carplexes, capsules by attaching different functionalities to 
polyhydroxy cavitands obtained from them. They could also be used for broad range of 
applications such as metal complexing agents, sensors, water soluble cavitands, phase 
transfer extraction of heavy metals, etc. moreover they could generate platforms for metal 
ligand exchange complexes, polymeric materials, self-assembled systems, 
enantioselective reaction sites as well as catalytic reactions.1-6  
 
OO OO O O OO
 
Figure 13. Methylene-bridged resorcinarene with a heptyl substituent. 
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3.2. Synthesis of Polyhydroxy resorcinares 
 
 This synthesis began with condensation of 2-methylresorcinol and heptaldehyde 
in the presence of hydrochloric acid and ethanol as a solvent at reflux temperature to give 
octahydroxy resorcinarene 2 with 88% yield after 24 h (Scheme 6).  
 
HO OH OO OO O O OO
HH H H HH H H
+
2
Ethanol, HCl
Reflux, 24 hrs
88% yield
 
                
                              Scheme 6. Synthesis of octahydroxy resorcinarene 2. 
 
 Hydroxy groups on adjacent aromatic rings of compound 2 were reacted with 
bromochloromethane and potassium carbonate in DMF to form methylene (-CH2-) 
bridges in compound 22. The compound 22 was isolated in 73 % yield (Scheme 7). Its 
spectral data was identical to that reported in literature.10,12
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OO OO O O OO
HH H H HH H H
OO OO O O OO
Bromochloromethane
DMF, K2CO3, 
65-70oC, 24 hrs
73% yield
222  
Scheme 7. Synthesis of methylene bridge resorcinarene 22. 
 
 Radical bromination of methyl group of resorcinarene 22 ring in presence of 
NBS/ AIBN in degassed benzene resulted in the formation of the tetrabromide 23 in 80 % 
yield (Scheme 8). 
 
OO OO O O OO OO OO O O OO
Br Br BrBr
22 23
NBS, AIBN,
 Benzene,
Reflux, 24 hrs
80% yield
 
Scheme 8. Synthesis of tetrabromo resorcinarene 23. 
  
 Once this tetrabromo resorcinarne 23 was in hand, we attempted its alkylation.  
Reaction of 23 with ethyl chloroformate using butyllithium as a base and the reduction of 
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the tetraester formed resulted in the tetraol 24 (Figure 14).  The synthesis of tetraol 
however was marred with low yield and tedious work-ups.  Synthesis of a tetraol 24 was 
also investigated through a Barbier reaction; tetrabromo resorcinarene was treated with 
Zn, formaldehyde in THF- aqueous ammonium chloride solvent system. Besides low 
yield, the reaction suffered with use of formaldehyde- a toxic compound. Clearly a 
modified strategy was needed. 
 
OO OO O O OO
OH OH OHOH
 
Figure 14. Tetraol 24 obtained from tetrabromo resorcinarene.  
 
 Tetrabromide 23 was therefore converted to octaester 25 in 75% yield by its 
reaction with diethyl malonate and sodium hydride in THF (Scheme 9). Compound was 
extracted in ethyl acetate, washed with brine solution and purified by column 
chromatography.  
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OO OO O O OO
Br Br BrBr
OO OO O O OO
EtOOC
EtOOC
COOEt
COOEt
EtOOC
COOEt
COOEt
COOEt
23 25
Diethyl malonate, 
THF, NaH
45oC, 24 hrs
 75% yield
 
Scheme 9. Formation of octaester 25 from tetrabromo resorcinarene. 
 
 Figure 15 shows the comparative proton NMRs of compound 25 and its starting 
material 23. It shows that the CH2Br resonance (D) at 4.4 ppm moves upfield to 
approximately 2.85 ppm after ester is formed and ethyl ester (-COOCH2CH3) resonance 
(A) appears at around 4.0 ppm. Molecular weight of the compound 25 was determined to 
be 1562 g/mol [Observed m/z = 1562 (M+)] from its APCI MS analysis. 
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             Figure 15. Comparative proton NMRs of compounds 25 and its precursor 23. 
 
 Octaester 25 was reduced by treating with sodium borohydride and lithium 
chloride to polyhydroxy resorcinarene 26 with 77% yield (Scheme 10). This compound 
was characterized from its detailed NMR analysis. 
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OO OO O O OO
EtOOC
EtOOC
COOEt
COOEt
EtOOC
COOEt
COOEt
COOEt
OO OO O O OO
HO
HO
OH OH HO OH
OH
OH
25 26
LiCl, NaBH4,
Ether, 3 days,
40oC, 77%
 
Scheme 10. Formation of polyhydroxy resorcinarene 26 from octaester resorcinarene. 
 
 Glycosylation of the octahydroxy compound 26 with D-glucose pentaacetate in 
presence of BF3-etherate and subsequent removal of the acetates groups using sodium 
methoxide solution in methanol led to compound 27 with 92% yield (Scheme 11). 
 
OO OO O O OO
HO
HO
OH OH HO OH
OH
OH
OO OO O O OO
GluO
GluO
OGlu OGlu GluO OGlu
OGlu
OGlu
26 27
(1) Glucose penta-acetate,
     DCM, BF3-Etherate,
      2 days, R.T., 84%
(2) NaOMe, Methanol
      10 hrs,  R.T., 92 %
 
Scheme 11. Glycosylation of compound 26 with glucose pentaacetate. 
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CHAPTER 4. EXPERIMENTAL 
 
 
4.1. General Experimental Procedure 
 
  
 All solvents and reagents were commercially available. Heptanal and 
diethylmalonate were purified by distillation. NMR spectra were recorded on 250 MHz, 
400 MHz and 500 MHz spectrometers. Mass spectra were recorded in APCI mode and 
using MALDI. 
 Synthesis of octahydroxy resorcinarene (1): - 2-Methylresorcinol (1.0 g, 8.1 
mmol) was dissolved in anhydrous ethanol (6.27 ml, 775 ml/mol) and 37% aqueous HCl 
(1.51 ml, 185 ml/mol). The solution was cooled in an ice bath and 2-Ethylbutanal (0.81 g, 
8.1 mmol) was added to the above solution slowly over a period of 30 min. Then the 
mixture was allowed to warm to room temperature. The reaction was then maintained at 
temperature of 45oC for nearly 3 hrs. Then the reaction mixture was poured onto 50 ml of 
ice cold water. The precipitate was filtered through a Buchner funnel and it was washed 
several times until it turned neutral to pH paper. It was dried and the NMR spectrum was 
taken. 
 1: 80%; 1H NMR (DMSO) δ 0.73 (m, 24H), 1.22 (m, 16H), 1.35 (m, 4H), 1.89 (s, 
6H) 1.92 (s, 6H), 4.01 (m, 4H), 7.18 (s, 4H), 8.82 (s, 8H). 
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 Synthesis of octahydroxy resorcinarene (2): - 2-Methylresorcinol (1.0 g, 8.1 
mmol) was dissolved in anhydrous ethanol (6.27 ml, 775 ml/mol) and 37% aqueous HCl 
(1.51 ml, 185 ml/mol). The solution was cooled in an ice bath and heptanal (1.13 ml, 8.1 
mmol)  was added to the above solution slowly over a period of 30 min. Then the mixture 
was allowed to warm to room temperature. The reaction was then maintained at 
temperature of 80oC, i.e. reflux for nearly 12 hrs after which we could see yellow colored 
precipitate. The precipitate was filtered through a Buchner funnel and it was washed 
several times until it turned neutral to pH paper. It was dried and the NMR spectrum was 
taken. The compound 3 was synthesized in same manner. 
 2: 88%; 1H NMR (DMSO) δ 0.84 (m, 12H), 1.23 (m, 32H), 1.93 (s, 12H), 2.21 (s, 
8H), 4.18 (m, 4H), 7.21 (s, 4H), 8.69 (bs, 8H). 
  3: 85%; 1H NMR (DMSO) δ 0.82 (m, 12H), 1.22 (m, 56H), 1.97 (m, 8H), 2.23 (s, 
12H), 4.28 (m, 4H), 7.15 (s, 4H), 8.64 (bs, 8H). 
 Synthesis of octahydroxy resorcinarene (4): - Resorcinol (1.0 g, 9.1 mmol) was 
dissolved in mixture of 3.5 ml anhydrous ethanol, 3.5 ml of water and 37% aqueous HCl 
(1.68 ml, 775 ml/mol). The solution was cooled in an ice bath and 2-Ethylbutanal (0.81 g, 
8.1 mmol) was added to the above solution slowly over a period of 30 min. Then the 
mixture was allowed to warm to room temperature and to stir at 45oC for nearly one day. 
Then the reaction mixture was poured into 50 ml of ice cold water. The light yellow-
colored precipitate was filtered through Buchner funnel and it was washed several times 
until it turned neutral to pH paper. It was dried and the NMR spectrum was taken. 
 4: 57%; 1H NMR (DMSO) δ 0.27 (m, 24H), 0.7 (m, 16H), 1.51 (m, 4H), 3.55 (m, 
4H), 6.01 (s, 4H), 7.36 (s, 4H), 9.01 (bs, 8H). 
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 Synthesis of octahydroxy resorcinarene (5): -Resorcinol (1.0 g, 9.1 mmol) was 
dissolved in anhydrous ethanol (7.1 ml, 77 5ml/mol) and 37% aqueous HCl (1.68 ml, 185 
ml/mol). The solution was cooled in an ice bath and heptanal (1.27 ml, 9.1 mmol)  was 
added to the above solution slowly over a period of 30 min. Then the mixture was 
allowed to warm to room temperature. The reaction was then maintained at temperature 
of 60oC for nearly 36 hrs. Then the reaction mixture was poured into 50 ml of ice cold 
water. The precipitate was filtered through Buchner funnel and it was washed several 
times until it turned neutral to pH paper. It was dried and the NMR spectrum was taken. 
  5: 78%; 1H NMR (DMSO) δ 0.82 (m, 12H), 1.21 (m, 32H) 2.07 (m, 8H), 4.23 
(m, 4H), 6.13 (s, 4H), 7.12 (s, 4H), 8.55 (s, 8H). 
 Synthesis of octahydroxy resorcinarene (6): - Resorcinol (1.0 g, 9.1 mmol) was 
dissolved in anhydrous ethanol (7.1 ml, 775 ml/mol) and 37% aqueous HCl (1.68 ml, 185 
ml/mol). The solution was cooled in an ice bath and  
decanal (1.71 ml, 9.1 mmol) was added to the above solution slowly over a period of 30 
min. Then the mixture was allowed to warm to room temperature. The reaction was then 
maintained at temperature of 45oC for nearly 24 hrs .The reaction mixture was poured 
into 50 ml of ice cold water which gave dark brown-colored precipitate. The precipitate 
was filtered through a Buchner funnel and it was washed several times until it turned 
neutral to pH paper. It was dried and the NMR spectrum was taken. 
 6: 62%; 1H NMR (DMSO) δ 0.78 (m, 12H), 1.12 (m, 56H), 1.95 (m, 8H), 4.17 
(m, 4H), 6.13 (s, 4H), 7.01 (s, 4H), 8.85 (bs, 8H). 
 Synthesis of octaallyloxy resorcinarene (7): -1g of Octahydroxy compound (1) 
was taken in a sealed tube and acetone (20 ml/mmol) was added to it. The reaction 
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mixture was stirred till homogenous mixture was formed. Then potassium carbonate (30 
eq.) was slowly added over a period of half an hour. Here we observed the change in 
color from brown to purple. Then allyl bromide (30 eq.) was added into it at room 
temperature. The reaction mixture was heated to temperature of 120oC for nearly 48 hrs. 
The reaction mixture was filtered and then concentrated. It was recrystallized using 50% 
acetone and 50 % methanol mixture. The NMR spectrum of crystals was taken. 13C NMR 
and DEPT 135 were taken on this compound since the proton NMR of this compound 
gave broad peaks. Compounds 8 and 9 were synthesized in same manner. 
  7: 36%; 1H NMR (CDCl3) δ 0.75 (m, 24H), 1.42 (m, 16H), 1.86 (m, 4H), 2.15 (s, 
12H), 3.95 (m, 16H), 4.55 (m, 4H), 5.24 (m, 16H), 5.91 (m, 8H), 6.65 (s, 4H); 13C NMR 
δ 10.3, 12.7, 22.2, 24.3, 36.4, 37.3, 40.2, 45.1, 48.2, 73.1, 74.5, 116.2, 16.7, 125.8, 127.3, 
134.4, 134.8, 135.6, 135.1. 
  8: 60%; 13C NMR (CDCl3) δ 10.7, 14.2, 22.9, 28.9, 29.8, 32.1, 35.4, 38.4, 73.3, 
116.2, 124.0, 124.0, 124.6, 134.6. 
  9: 55%; 1H NMR (CDCl3) δ 0.82 (t, 12H, J = 7.2 Hz), 1.26 (m, 56H), 1.85 (m, 
8H), 2.15 (s, 12H), 4.25 (m, 16H), 4.55 (m, 4H), 5.25 (m, 16H), 6.13 (m, 8H), 6.55 (s, 
4H); 13C NMR δ 10.6, 10.9, 14.2, 22.8, 28.6, 28.9, 29.5, 30.2, 32.1, 33.5, 34.1, 35.4, 36.5, 
37.4, 37.9, 38.4, 38.7, 40.0, 73.3, 73.7, 73.9, 74.5, 74.7, 116.2, 116.4, 116.7, 117.0, 117.3, 
124.0, 124.5, 124.7, 124.9, 130.2, 131.7, 133.9, 134.4, 134.6, 134.7, 134.8, 136.8, 153.6, 
153.9, 154.6, 155.2. 
 Synthesis of octaallyloxy resorcinarene (10): - 1.0 g of octahydroxy compound 
(4) was added to sealed tube and acetone (20 ml/mol) was added to it. The reaction 
mixture was stirred till homogenous mixture was formed. Then potassium carbonate (30 
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eq.) was added to the reaction mixture. Here we observed the change in color from brown 
to purple. Then allyl bromide (30 eq.) was added. The reaction mixture was heated to 
temperature of 90oC for nearly 48 hrs. The reaction mixture was filtered and then 
concentrated. It was recrystallized using acetone and methanol mixture. 13C NMR, 1H 
NMR spectrums of crystals were taken. Compounds 11 and 12 were also synthesized in 
same fashion. 
  10: 15%; 1H NMR (CDCl3) δ 0.65 (m, 24H), 1.19-1.25 (m, 16H), 1.42 (m, 4H), 
4.21 (m, 16H), 4.33 (m, 4H), 5.22 (m, 16H), 5.94 (m, 8H), 6.22 (s, 4H), 6.95 (s, 4H).  
 11: 22%; 1H NMR (CDCl3) δ 0.73 (t, 12H, J = 7.2 Hz), 1.12-1.23 (m, 32H,), 1.72 
(m, 8H), 4.11 (d, 8H, J = 12.0 Hz), 4.28 (dd, 8H, J = 12.0 Hz), 4.51 (t, 4H, J = 4.0 Hz), 
5.11 (d, 8H, J = 8.0 Hz), 5.29  (d, 8H, J = 16.0 Hz), 5.82 (m, 8H), 6.11 (s, 4H,), 6.52 (s, 
4H). 13C NMR δ 14.1, 21.0, 22.8, 28.3, 29.7, 31.9, 34.7, 35.8, 69.6, 99.3, 116.1, 125.9, 
134.1, 154.8. 
 12: 20%; 1H NMR (CDCl3) δ 0.81 (t, 12H, J = 7.2 Hz), 1.23-1.31 (m, 56H), 1.85 
(m, 8H), 4.13 (d, 8H, J = 12.0 Hz), 4.31 (d, 8H, J = 12.0 Hz), 4.59 (t, 4H, J = 4.0 Hz), 
5.13 (d, 8H, J = 8.0 Hz), 5.31 (d, 8H, J = 16.0 Hz), 5.94 (m, 8H), 6.35 (s, 4H), 6.65 (s, 
4H). 
 Synthesis of bridged-resorcinarene (13): - To a stirred solution of octa-allyloxy-
pentyl-methylresorcinarene (7) (1.0 gm, 0.86 mmole) in dry methylene chloride (90 ml) 
was added grubb’s catalyst (10 mole %, 0.071 gm, 0.086 mmole) in dry methylene 
chloride (20 ml) at room temperature. The reaction was continued for 4 days. The 
reaction mixture was then concentrated over rotavapor and column chromatography was 
run using 10% ethyl acetate and 90% hexane solvent system to separate two spots. The 
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second spot (fraction) proved to be desired ring closed compound with 35% yield. The 
compound was confirmed by 13C, DEPT, HSQC, Mass spectroscopy. 1H NMR (CDCl3) δ 
0.21 (m, 24H), 1.02-0.71 (set of m, 16H), 1.31 (m, 4H), 2.23 (s, 12H), 4.81-4.21 (set of 
m, 16H), 5.22 (m, 4H), 6.23- 5.92 (set of m, 8H), 7.02 (s, 4H); 13C NMR (CDCl3) δ in 
ppm 9.9, 10.1, 10.3, 10.8, 10.9, 11.5, 12.0, 14.3, 22.3, 23.1, 37.5, 39.8, 41.5, 42.1, 42.7, 
43.4, 47.5, 49.8, 51.6, 60.5, 69.5, 123.8, 124.0, 124.3, 124.5, 125.0, 125.7, 126.0, 126.7, 
127.1, 127.4, 127.8, 128.2, 130.5, 131.0, 132.0, 132.4, 132.7, 132.9, 133.1, 133.2, 133.5, 
134.5, 134.6, 150.9, 155.0, 156.5, 171.3; APCI m/z 1033.7 (M+H+). 
  Synthesis of bridged-resorcinarene (14): - To a stirred solution of octa-allyloxy- 
heptyl-methylresorcinarene (8) (1.0 gm, 0.83 mmole) in dry methylene chloride (87 ml) 
was added grubb’s catalyst (8 mole %, 0.054 gm, 0.066 mmole) in dry methylene 
chloride 920ml) at room temperature. The reaction was continued for 4 days. The 
reaction mixture was then concentrated over rotavapor and column chromatography was 
run using 10% ethyl acetate and 90% hexane solvent system to separate two spots. The 
second spot (fraction) proved to be desired ring closed compound. Recrystallization from 
methanol-ethyl acetate yielded 27 (59%) as a white crystalline solid. It was confirmed by 
1H NMR, COSY, 13C, DEPT, HSQC, Mass spectroscopy and X-ray diffraction method. 
1H NMR (CDCl3) δ in ppm 0.82 (t, 12H, J = 6.8 Hz), 1.27-1.20 (set of m, 32H), 1.85 (m, 
8H), 2.18 (s, 12H), 4.45 (d, 8H, J = 12.4 Hz), 4.73 (dd, 8H, J = 2.4 Hz, J = 12.8 Hz), 4.82 
(t, 4H, J = 8.0 Hz), 5.88 (bs, 8H), 7.03 (s, 4H); 13C NMR (CDCl3) δ in ppm 11.5, 14.2, 
22.9, 28.0, 29.6, 32.1, 36.1, 37.2, 71.0, 123.7, 129.14, 133.5, 154.9; APCI m/z 1089.7 
(M+H+). 
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   Synthesis of bridged-resorcinarene (15): - To a stirred solution of octa-allyloxy 
decyl methylresorcinarene (9) (1.0 gm, 0.73 mmole) in dry methylene chloride (77 ml) 
was added grubb’s catalyst (8 mole %, 0.048 gm, 0.058 mmole) in dry methylene 
chloride (17 ml) at room temperature. The reaction was continued for 4 days. The 
reaction mixture was then concentrated over rotavapor and column chromatography was 
run using 10% ethyl acetate and 90% hexane solvent system to separate two spots. The 
second spot (fraction) proved to be desired ring closed compound with 61% yield. It was 
confirmed by 1H NMR, COSY, 13C, DEPT, HSQC, Mass spectroscopy. 1H NMR 
(CDCl3) δ 0.83 (t, 12H, J = 6.8 Hz), 1.24-1.12 (set of m, 32H), 1.82 (m, 8H), 2.14 (s, 
12H), 4.41 (d, 8H, J = 12.0 Hz), 4.68 (dd, 8H, J = 3.4 Hz, J = 12.5 Hz), 4.76 (t, 4H, J = 
7.6 Hz), 5.85 (bs, 8H), 7.01 (s, 4H); 13C NMR (CDCl3) δ in ppm 10.3, 13.0, 21.6, 26.9, 
28.3, 28.6, 28.7, 28.8, 30.9, 34.9, 35.9, 69.7, 122.5, 127.9, 132.3, 153.6; APCI m/z 1257.9 
(M+H+). 
 Synthesis of bridged-resorcinarene (16): - To a stirred solution of octa-allyloxy- 
heptyl-resorcinarene (11) (1.0 gm, 0.87 mmole) in dry methylene chloride (91 ml) was 
added grubb’s catalyst (8 mole %, 0.057 gm, 0.07 mmole) in dry methylene chloride (20 
ml) at room temperature. The reaction was continued for 4 days. The reaction mixture 
was then concentrated over rotavapor and column chromatography was run using 10% 
ethyl acetate and 90% hexane solvent system to separate two spots. The second spot 
(fraction) showed that four allyl groups were closed forming two bridges with 32% yield. 
It was confirmed by 1H NMR, COSY, 13C, DEPT, HSQC, Mass spectroscopy. 1H NMR 
(CDCl3) δ 0.77 (t, 12H, J = 6.2 Hz), 1.13-1.73 (set of m, 32H), 1.85 (m, 8H), 4.25 (m, 
16H), 4.55 (d, 2H, J = 2.5 Hz), 4.62 (s, 2H), 5.18 (dd, 4H, J = 1.2 Hz, J = 10.5 Hz), 5.41 
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(dd, 4H, J = 1.5 Hz, J = 17.5 Hz), 5.86 (s, 2H), 5.93 (s, 2H), 6.12 (m, 4H), 6.45 (s, 4H), 
7.12 (s, 4H); 13C NMR (CDCl3) δ in ppm 13.0, 21.7, 27.2, 28.7, 30.9, 33.4, 34.5, 63.6, 
68.9, 96.8, 98.2, 115.3, 125.3, 125.6, 123, 127.0, 129, 133.3, 152, 153; MALDI m/z 
1090.039 (M+), 1112.068 (M+Na+). 
  Synthesis of bridged-resorcinarene (17): - To a stirred solution of octa-allyloxy 
decyl resorcinarene (12) (1.0 gm, 0.76 mmole) in dry methylene chloride (80 ml) was 
added grubb’s catalyst (8 mole %, 0.05 gm, 0.061 mmole) in dry methylene chloride (17 
ml) at room temperature. The reaction was continued for 4 days. The reaction mixture 
was then concentrated over rotavapor and column chromatography was run using 10% 
ethyl acetate and 90% hexane solvent system to separate two spots. The second spot 
(fraction) showed that four allyl groups were closed forming two bridges with 35% yield. 
It was confirmed by 1H NMR, COSY, 13C, DEPT, HSQC, Mass spectroscopy. 1H NMR 
(CDCl3) δ 0.79 (t, 12H, J = 6.2 Hz), 1.12-1.73 (set of m, 32H), 1.98 (m, 8H), 4.34 (m, 
16H), 4.68 (s, 2H), 4.77 (s, 2H), 5.19 (dd, 4H, J = 1.2 Hz, J = 10.2 Hz), 5.43 (dd, 4H, J = 
1.5 Hz, J = 17.0 Hz), 5.88 (s, 2H), 5.95 (s, 2H), 6.11 (m, 4H), 6.45 (s, 4H), 7.12 (s, 4H); 
13C NMR (CDCl3) δ in ppm 13.0, 21.6, 27.2, 28.3, 28.7, 28.7, 29.0, 30.9, 33.4, 34.4, 34.5, 
63.5, 68.9, 96.8, 98.1, 115.3, 122.7, 125.3, 125.6, 127.0, 128.7, 133.3, 152.0, 153.2; 
MALDI m/z 1257.676 (M +H+). 
 Synthesis of bridged-resorcinarene (20): - To a stirred solution of octa-allyloxy- 
methyl-methylresorcinarene (18) (1.0 gm, 1.086 mmole) in dry methylene chloride (114 
ml) was added grubb’s catalyst (8 mole%, 0.071 gm, 0.087 mmole) in dry methylene 
chloride (25 ml) at room temperature. The reaction was continued for 4 days. The 
reaction mixture was then concentrated over rotavapor and column chromatography was 
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run using 10% ethyl acetate and 90% hexane solvent system to separate four spots. The 
fourth spot (fraction) showed that two allyl groups were closed forming one bridge. It 
was confirmed by Mass spectroscopy. MALDI m/z 893.796 (M+H+), 915.843 (M+Na+), 
933.844 (M+K+).  
 Synthesis of bridged-resorcinarene (21): - To a stirred solution of octa-allyloxy- 
methyl-resorcinarene (1.0 gm, 1.156 mmole) in dry methylene chloride (121 ml) was 
added grubb’s catalyst (8 mole %, 0.075 gm, 0.092 mmole) in dry methylene chloride (26 
ml) at room temperature. The reaction was continued for 4 days. The reaction mixture 
was then concentrated over rotavapor and column chromatography was run using 10% 
ethyl acetate and 90% hexane solvent system to separate four spots. The fourth spot 
(fraction) showed that two allyl groups were closed forming one bridge. It was confirmed 
by Mass spectroscopy. APCI m/z 837.4 (M+H+), 854.5 (M+H2O).   
 Synthesis of methylene-bridged heptyl resorcinarene (22): - Octahydroxy-
heptyl-methylresorcinarene (2) (1.0 g, 1.1 mmol) was dissolved in DMF (11 ml, 10 
lit/mol) at room temperature. Potassium carbonate (2.43 g, 17.6 mmol) was added to it at 
0oC. It was stirred for 30 min., then added bromochloromethane (1.54 ml, 17.6 mmol) 
and heated upto 65-70oC. After 24 hrs, TLC showed the appearance of top spot and 
starting material was totally consumed. The reaction mixture was filtered off and DMF 
was distilled. The residue was taken in DCM and extracted with brine solution. DCM was 
then concentrated over rotavapor and compound was separated by column in 10% ethyl 
acetate and 90% hexane solvent system to give 73% yield. It was confirmed by 1H NMR, 
13C, DEPT. 13C NMR (CDCl3) δ in ppm 10.5, 14.2, 14.3, 22.8, 18.12, 29.72, 30.16, 
30.31, 32.08, 37.04, 37.08, 37.18, 60.54, 98.7, 117.77, 123.79, 138.12, 153.43. 
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 Synthesis of Tetrabromo resorcinarene (23): - Methylene bridged heptyl 
resorcinarene (22) (1.0 g, 1.1 mmol) was dissolved in (20.9 ml, 19 lit/mol) degassed 
benzene. NBS (1.17 g, 6.6 mmol) and AIBN (0.018 g, 0.11 mmol) were added to reaction 
mixture at room temperature. The reaction mixture was refluxed for 24 hrs. After 24 hrs, 
observing TLC to make sure that starting material is consumed and new spot appeared at 
higher Rf value, the reaction mixture was taken for work-up. It was first filtered off to 
separate succinimide and then benzene was concentrated over rotavapor. The Column 
was run in 10% ethyl acetate and 90 % hexane solvent system and the compound was 
crystallized out from acetone with 80% yield. It was confirmed by 1H NMR, 13C NMR 
and DEPT. 1H NMR (CDCl3) δ 0.87 (t, 12H, J = 6.8 Hz), 1.28 (set of m, 24H), 1.41 (q, 
8H, J = 5.2 Hz), 1.97 (s), 2.17 (q, 8H, J = 6.4 Hz), 4.39 (s, 8H), 4.52 (d, 4H, J = 6.4 Hz), 
4.75 (t, 4H, J = 7.6 Hz), 6.02 (d, 4H, J = 6.0 Hz), 7.11 (s, 4H); 13C NMR (CDCl3) δ in 
ppm 22.7, 23.0, 27.9, 29.5, 30.2, 31.9, 37.0, 98.3, 121.1, 124.6, 138.2, 153.7. 
 Synthesis of Octa-ester resorcinarene (25): - To a stirred solution of distilled 
diethyl malonate (0.74 ml, 4.8 mmole) in dry THF (8 ml, 10 lit/mol) at 0oC was added 
NaH (0.1152 g, 4.8 mmole) portionwise under nitrogen atmosphere. The reaction was 
stirred for 20 min and solution of tetrabromo resorcinarene (23) (1.0 g, 0.8 mmol) was 
added over a 90 min period. The reaction mixture was then warmed to room temperature 
and the reaction was continued for 24 hrs. It was also heated to 45oC for 12 more hrs. 
TLC was checked to make sure that starting material was consumed and a new spot 
appeared at lower Rf value, the reaction mixture was taken for work-up. It was first 
concentrated under reduced pressure and the viscous liquid was taken up in ethyl acetate, 
extracted with brine solution. An organic layer was dried over sodium sulfate and 
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concentrated. The column was run in a 30% ethyl acetate and 70% hexane solvent system 
to get the product in 75 % yield. The compound was confirmed by 1H NMR, 13C NMR 
and DEPT. 1H NMR (CDCl3) δ 0.82(t, 12H, J = 5.0 Hz), 1.04 (t, 24H, J = 6.2 Hz), 1.13 
(t, 8H, J = 7.5 Hz), 1.33-1.27 (set of m, 24H), 2.11 (bs, 8H), 1.55 (s), 2.85 (d, 8H, J = 5.5 
Hz), 3.52 (t, 4H, J = 7.5 Hz), 4.02 (p, 16H, J = 6.7 Hz), 4.12 (d, 4H, J = 6.2 Hz), 4.63 (t, 
4H, J = 7.5 Hz), 5.76 (d, 4H, J = 6.5 Hz), 6.95 (s, 4H). MALDI m/z 1562.174 (M+), 
1584.264 (M+Na+).  
 Synthesis of Octahydroxy resorcinarene (26): - Octa-ester resorcinarene (25) 
(1.0 g, 0.64 mmol) was solublized in ether (12.8 ml, 20 lit/mol) and LiCl (0.435 g, 10.2 
mmole) was added to it at 0oC. the reaction mixture was then stirred for additional 10 
minutes. NaBH4 (0.386 g, 10.2 mmole) was then added portionwise over 30 minutes 
period. The reaction mixture was warmed to room temperature and allowed to stir for 48 
hrs at 40oC. TLC was checked to make sure that starting material was consumed and a 
new spot appeared at lower Rf value, the reaction mixture was taken for work-up. It was 
first quenched with methanol. It was concentrated over rotavapor. The residue was taken 
in DCM and extracted with aqueous NH4Cl. An organic layer was dried over sodium 
sulfate and concentrated to get product in 77% yield. The compound was confirmed by 
1H NMR, 13C NMR and DEPT. 1H NMR (DMSO) δ 0.8 (t, 12H, J = 7.0 Hz), 1.21-1.18 
(set of m, 24H), 1.28 (s, 8H), 1.33 (bs, 8H), 2.28 (m, 4H), 3.18 (s, 8H), 3.35 (s, 16H), 
3.51 (s, 4H), 4.51 (bs, 4H), 5.71 (d, 4H, J = 2.0 Hz), 7.39 (bs, 8H). 
 Synthesis of Glycosilated resorcinarene (27): - Octa-acid resorcinarene (26) (1.0 
g, 0.8 mmol) and D-glucose pentaacetate (2.5 g, 6.4 mmol) were solublized in DCM (16 
ml, 20 lit/mol) and the reaction mixture was cooled to 0oC. BF3-etherate (4.5 ml, 32.0 
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mol) was added to the reaction mixture. The reaction mixture was warmed upto room 
temperature and allowed to stir for 48 hrs at room temperature. TLC was checked to 
make sure that starting material was consumed and a new spot appeared at higher Rf 
value, the reaction mixture was taken for work-up. It was first neutralized with sodium 
bicarbonate solution. It was concentrated over rotavapor. The residue was then extracted 
with ethyl acetate and washed with water till neutral pH. An organic layer was dried over 
sodium sulfate and concentrated to get product with 84% yield. The product was 
subsequently deacetylated by 0.022N sodium methoxide solution (1.6 ml, 60 lit/mol) in 
methanol (16 ml, 20 lit/mol). After 10 hrs, TLC was checked and appearance of lower 
spot was observed. The starting material was completely deacetylated. It was neutralized 
by proton exchange Dowex resin. The reaction mixture was filtered and methanol was 
evaporated to give compound 30 in 92% yield. It was confirmed by 1H NMR, 13C NMR 
and DEPT. 13C NMR (CDCl3) δ in ppm 20.7, 20.8, 20.9, 61.6, 67.9, 68.0, 69.4, 70.0, 
70.4, 72.9, 89.2, 91.9, 169.1, 169.4, 169.6, 170.3, 170.8.  
 
 
4.2. Crystal structure data of Resorcinarenes 
 
(1) Crystal data of allyloxy-methyl-methylresorcinarene (18): -                  
  Colorless parallelepiped, C60H72O8, F.W.= 921.18, triclinic, space group P1, a= 
9.774(3), b= 15.987(4), c= 17.049(4) A0, β= 84.594(16)0, V= 2582(12) A0 3, Z= 2, Dα = 
1.185 Mg m-3, T= 110 K. Data were collected on Kappa CCD diffractometer (2.50 < θ < 
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29.50) using Mo Kα radiation, (λ= 0.71073A0 ). From the 9131 reflections measured, 
4539 (I > 2σ (I)) were used in the refinements. 
 
(2) Crystal data of allyloxy-pentyl-methylresorcinarene (7): - 
 
 Colorless parallelepiped, C76H104O8, F.W.= 1145.59, triclinic, space group P1, a= 
12.0664(10), b= 15.9274(12), c= 20.1225(15) A0, β= 96.660(5)0, V= 3369(5) A0 3, Z= 2, 
Dα = 1.129 Mg m-3, T= 115 K. Data were collected on Kappa CCD diffractometer (2.50 
< θ < 29.50) using Mo Kα radiation, (λ= 0.71073 A0). From the 14249 reflections 
measured, 11348 (I > 2σ (I)) were used in the refinements. 
(3) Crystal structure of bridged-heptyl-methylresorcinarene (14): - 
  Colorless prism, C72H96O8.0.5 (C4H8O2), F.W.= 1133.54, monoclinic, space group 
P21/c, a= 17.333(2), b= 34.347(4), c= 23.388 (2) A0, β= 110.586(6)0, V= 13035(2) A0 3, 
Z= 8, Dα = 1.155 Mg m-3, T= 115 K. Data were collected on Kappa CCD diffractometer 
(2.50 < θ < 230) using Mo Kα radiation, (λ= 0.71073 A0). From the 18119 reflections 
measured, 10173 (I > 2σ (I)) were used in the refinements. 
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                                            Figure 16. 1H NMR of compound 1. 
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                                             Figure 17. 1H NMR of compound 3. 
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                                       Figure 18. 1H NMR of compound 4. 
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                                            Figure 19. 1H NMR of compound 6. 
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                                          Figure 20. 1H NMR of compound 7. 
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                                           Figure 21. 13C NMR of compound 8. 
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                                                Figure 22. 1H NMR of compound 9. 
 
 
 
                                              Figure 23. 13C NMR of compound 9. 
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                                         Figure 24. 1H NMR of compound 10. 
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                                        Figure 25. 1H NMR of compound 11.              
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                                        Figure 26. 1H NMR of compound 12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                 Figure 27. 13C NMR of compound 12. 
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                                   Figure 28. 1H NMR of compound 13. 
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                                            Figure 29. 13C NMR of compound 13. 
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                                   Figure 30. 1H NMR of compound 14.  
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Figure 31. 13C NMR of compound 14. 
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Figure 32. 1H NMR of compound 15. 
 
 
 
Figure 33. 13C NMR of compound 15. 
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Figure 34. 1H NMR of compound 16. 
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                                         Figure 35. 1H NMR of compound 17. 
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Figure 36. 13C NMR of compound 17. 
 
 
 
 
Figure 37. 13C NMR of compound 22. 
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Figure 38. 1H NMR of compound 23. 
 
 
 
 
Figure 39. 13C NMR of compound 23. 
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Figure 40. 1H NMR of compound 25. 
 
 
 
 
Figure 41. 1H NMR of compound 26. 
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Figure 42. 1H NMR of compound 27. 
 
 
 
 
 
Figure 43. 13C NMR of compound 27. 
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                   Figure 44. gCOSY of compound 13. 
 
                Figure 45. gHSQC of compound 13. 
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Figure 46. gHSQC of compound 15. 
 
 
 
Figure 47. gCOSY of compound 15. 
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Figure 48. DEPT of compound 27 ( expanded NMR). 
 
Figure 49. DEPT of compound 27. 
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